Liting Zhai

Title: Liting Zhai: Innovator in Neuropilin-2 Research

Introduction

Liting Zhai is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biomedical research. He holds two patents that focus on innovative compositions and methods involving anti-neuropilin-2 (NRP2) antibodies. His work aims to advance therapeutic strategies for diseases associated with NRP2.

Latest Patents

Liting Zhai's latest patents include compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 (NRP2) polypeptides. The inventions include those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, such as human histidyl-tRNA synthetase (HRS). This modulation influences subsequent NRP2-mediated downstream signaling events, leading to related therapeutic compositions and methods for modulating NRP2 activity and treating NRP2-associated diseases.

Career Highlights

Liting Zhai is currently associated with Atyr Pharma, Inc., where he continues to develop innovative solutions in the realm of therapeutic antibodies. His research has the potential to impact the treatment of various diseases linked to NRP2, showcasing his commitment to advancing medical science.

Collaborations

Liting Zhai collaborates with notable colleagues, including Luke Burman and Yee Ting (Esther) Chong. These partnerships enhance the research environment and contribute to the development of groundbreaking therapeutic strategies.

Conclusion

Liting Zhai's work in the field of neuropilin-2 research exemplifies the innovative spirit of modern biomedical science. His patents and collaborations reflect a dedication to improving therapeutic options for patients with NRP2-associated diseases.